RETROOCULAR FIBROBLASTS - IMPORTANT EFFECTOR-CELLS IN GRAVES OPHTHALMOPATHY

被引:46
作者
BAHN, RS
HEUFELDER, AE
机构
[1] Division of Endocrinology, Mayo Clinic/Foundation, Rochester
关键词
D O I
10.1089/thy.1992.2.89
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Retroocular and pretibial fibroblasts are likely important effector cells in Graves' ophthalmopathy and pretibial dermopathy. Histologic similarities exist between the tissues involved in these clinically diverse extrathyroidal manifestations of Graves' disease. Both conditions are characterized by an accumulation of glycosaminoglycans (GAGs) and an infiltration of lymphocytes. We have shown that particular cytokines, probably released by the local inflammatory cell infiltrate, are capable of stimulating GAG synthesis by retroocular and pretibial fibroblasts. In order to explain the site-selective involvement of these anatomically distinct areas in Graves' disease, we sought to identify unique characteristics shared by retroocular and pretibial fibroblasts. We have shown that affected retroocular and pretibial fibroblasts demonstrate an enhanced HLA-DR response to interferon-gamma treatment and that retroocular fibroblasts are especially sensitive to the GAG-stimulating effect of this cytokine. In addition, we have shown that only affected retroocular and pretibial fibroblasts express the 72 kDa heat shock protein. Therefore, affected retroocular and pretibial fibroblasts possess unique immunologic features that may render them more susceptible to the autoimmune process in Graves' disease. Chronic stimulation of fibroblasts by cytokines released in the local inflammatory milieu may result in excessive GAG production by these cells. The accumulation of these hydrophilic mucopolysaccharides, with attendant edema, leads to the clinical manifestations of Graves' ophthalmopathy and pretibial dermopathy.
引用
收藏
页码:89 / 94
页数:6
相关论文
共 45 条
  • [1] CLINICAL REVIEW-13 - DIAGNOSIS AND MANAGEMENT OF GRAVES OPHTHALMOPATHY
    BAHN, RS
    GARRITY, JA
    GORMAN, CA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 71 (03) : 559 - 563
  • [2] HUMAN RETROOCULAR FIBROBLASTS INVITRO - A MODEL FOR THE STUDY OF GRAVES OPHTHALMOPATHY
    BAHN, RS
    GORMAN, CA
    WOLOSCHAK, GE
    DAVID, CS
    JOHNSON, PM
    JOHNSON, CM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 65 (04) : 665 - 670
  • [3] PRESENCE OF ANTIBODIES IN THE SERA OF PATIENTS WITH GRAVES-DISEASE RECOGNIZING A 23 KILODALTON FIBROBLAST PROTEIN
    BAHN, RS
    GORMAN, CA
    JOHNSON, CM
    SMITH, TJ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 69 (03) : 622 - 628
  • [4] ROLE OF MHC GENE-PRODUCTS IN IMMUNE REGULATION
    BENACERRAF, B
    [J]. SCIENCE, 1981, 212 (4500) : 1229 - 1238
  • [5] BOTTAZZO GF, 1983, LANCET, V2, P1115
  • [6] CAMPBELL RJ, 1989, ACTA ENDOCRINOL-COP, V121, P9
  • [7] A ROLE FOR A 70-KILODATON HEAT-SHOCK PROTEIN IN LYSOSOMAL DEGRADATION OF INTRACELLULAR PROTEINS
    CHIANG, HL
    TERLECKY, SR
    PLANT, CP
    DICE, JF
    [J]. SCIENCE, 1989, 246 (4928) : 382 - 385
  • [8] INTRATHYROIDAL MHC CLASS-II ANTIGEN EXPRESSION AND THYROID AUTOIMMUNITY
    DAVIES, TF
    PICCININI, LA
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1987, 16 (02) : 247 - 268
  • [9] INDUCTION AND THERAPY OF AUTOIMMUNE DIABETES IN THE NON-OBESE DIABETIC (NOD/LT) MOUSE BY A 65-KDA HEAT-SHOCK PROTEIN
    ELIAS, D
    MARKOVITS, D
    RESHEF, T
    VANDERZEE, R
    COHEN, IR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (04) : 1576 - 1580
  • [10] FORBES G, 1986, AM J NEURORADIOL, V7, P651